Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie halts late-stage TAHOE study of Rova-T in small-cell lung cancer

firstwordpharmaDecember 06, 2018

Tag: small-cell lung cancer , AbbVie , late-stage , Rova-T , small-cell lung cancer

PharmaSources Customer Service